Recurrent Squamous Cell Carcinoma of the Hypopharynx Terminated Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0029504 (Recurrent Squamous Cell Carcinoma of the Hypopharynx)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01249443Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTreatment